ProCE Banner Activity

BCMA-Targeted CAR T-Cell Therapy: Where Are We And Where Are We Going?

Slideset Download
Download this slideset based on the content from a live stream CCO webinar from Thomas G. Martin, MD, on how to integrate CAR T-cell therapy for patients with relapsed/refractory multiple myeloma.

Released: September 10, 2021

Expiration: September 09, 2022

No longer available for credit.
Begin Activity

Share

Faculty

Thomas G. Martin

Thomas G. Martin, MD

Associate Clinical Professor of Medicine
Associate Director
, Myeloma Institute
University of California, San Francisco Medical Center
San Francisco, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

GlaxoSmithKline

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Faculty Disclosure

Primary Author

Thomas G. Martin, MD

Associate Clinical Professor of Medicine
Associate Director
, Myeloma Institute
University of California, San Francisco Medical Center
San Francisco, California